We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$1.88B
AUM Growth
+$96.4M
Cap. Flow
+$24.5M
Cap. Flow %
1.3%
Top 10 Hldgs %
12.98%
Holding
2,267
New
450
Increased
725
Reduced
692
Closed
392

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$13.6M
2
XOM icon
ExxonMobil
XOM
+$10.3M
3
IBM icon
IBM
IBM
+$10.3M
4
AMZN icon
Amazon
AMZN
+$9.32M
5
USB icon
US Bancorp
USB
+$7.89M

Sector Composition

Rank Sector Weight
1 Technology 13.87%
2 Financials 13.85%
3 Consumer Discretionary 12.52%
4 Industrials 12.07%
5 Healthcare 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENOV icon
1826
Enovis
ENOV
$1.68B
$25K ﹤0.01%
373
-13,371
-97% -$900K
AFMD
1827
DELISTED
Affimed
AFMD
$24K ﹤0.01%
+1,859
New +$35.3K
PLYA
1828
DELISTED
Playa Hotels & Resorts
PLYA
$24K ﹤0.01%
2,223
-16,628
-88% -$177K
NNA
1829
DELISTED
Navios Maritime Acquisition Corporation
NNA
$24K ﹤0.01%
1,468
WOLF icon
1830
Wolfspeed
WOLF
$1.23B
$23K ﹤0.01%
+607
New +$20.9K
AMPH icon
1831
Amphastar Pharmaceuticals
AMPH
$879M
$22K ﹤0.01%
+1,123
New +$21K
ARQL
1832
DELISTED
Arqule Inc
ARQL
$22K ﹤0.01%
13,286
+10,211
+332% +$13.2K
RBA icon
1833
RB Global
RBA
$20.4B
$21K ﹤0.01%
+700
New +$19.6K
TELL
1834
DELISTED
Tellurian Inc.
TELL
$21K ﹤0.01%
+2,171
New +$23.3K
GAU
1835
Galiano Gold
GAU
$455M
$20K ﹤0.01%
28,200
-2,300
-8% -$1.86K
APOG icon
1836
Apogee Enterprises
APOG
$826M
$19K ﹤0.01%
+424
New +$20.2K
ACGN
1837
DELISTED
Aceragen Inc
ACGN
$19K ﹤0.01%
+65
New +$18.6K
IMBI
1838
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$19K ﹤0.01%
+1,357
New +$17.3K
RARX
1839
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$19K ﹤0.01%
+2,179
New +$26.8K
JONE
1840
DELISTED
Jones Energy, Inc.
JONE
$18K ﹤0.01%
+810
New +$18.9K
WG
1841
DELISTED
Willbros Group
WG
$18K ﹤0.01%
+12,338
New +$25.8K
NVRO
1842
DELISTED
NEVRO CORP.
NVRO
$17K ﹤0.01%
251
-149
-37% -$11.9K
USCR
1843
DELISTED
U S Concrete, Inc.
USCR
$17K ﹤0.01%
200
-658
-77% -$51.8K
ARRY
1844
DELISTED
Array Biopharma Inc
ARRY
$17K ﹤0.01%
1,331
-11,316
-89% -$129K
AUPH icon
1845
Aurinia Pharmaceuticals
AUPH
$1.91B
$16K ﹤0.01%
+3,472
New +$19.3K
DYN
1846
DELISTED
Dynegy, Inc.
DYN
$16K ﹤0.01%
1,380
-25,774
-95% -$288K
CSII
1847
DELISTED
Cardiovascular Systems, Inc.
CSII
$13K ﹤0.01%
543
-4,118
-88% -$104K
GEN
1848
DELISTED
Genesis Healthcare, Inc.
GEN
$13K ﹤0.01%
17,237
DO
1849
DELISTED
Diamond Offshore Drilling
DO
$13K ﹤0.01%
700
-5,432
-89% -$88.3K
EXAS
1850
DELISTED
Exact Sciences
EXAS
$12K ﹤0.01%
228
-4,048
-95% -$216K

Similar funds

Cubist Systematic Strategies's Q4 2017 Portfolio in Review

As of Q4 2017, Cubist Systematic Strategies held 2,267 positions worth $1.88B, up 5.4% from $1.79B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Cubist Systematic Strategies's Q4 2017 filing shows 450 new, 725 increased, 692 reduced and 392 closed positions. Its largest new stake was US Bancorp: 146,673 shares worth $7.86M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $94.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cubist Systematic Strategies's largest Q4 2017 buy was US Bancorp: 146,673 shares worth $7.86M.
  • Cubist Systematic Strategies added most to Boston Scientific in Q4 2017, an estimated $13.6M increase.
  • Cubist Systematic Strategies's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $94.4M.
  • Cubist Systematic Strategies fully exited Varian Medical Systems, Inc. in Q4 2017, selling an estimated $4.24M.
  • Cubist Systematic Strategies's ten largest holdings make up 13% of its $1.88B portfolio in Q4 2017.
  • Cubist Systematic Strategies opened 450 new positions and closed 392 in Q4 2017.
  • Cubist Systematic Strategies's portfolio value rose 5.4% quarter-over-quarter to $1.88B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2017, filed 14 Feb 2018.